Related Experiment Video
Updated: Apr 26, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Bordetella pertussis fimbriae (Fim): relevance for vaccines
Andrew R Gorringe1, Thomas E Vaughan
1Public Health England, Porton Down, Salisbury SP4 0JG, UK.
Abstract:
Bordetella pertussis produces two serologically distinct fimbriae, Fim2 and Fim3. Expression of these antigens is governed by the BvgA/S system and by the length of a poly(C) tract in the promoter of each gene. Fim2 and Fim3 are important antigens for whole cell pertussis vaccines as clinical trials have shown an association of anti-fimbriae antibody-mediated agglutination and protection. The current five component acellular pertussis vaccine contains co-purified Fim2/3 and provided good efficacy in clinical trials with the anti-Fim antibody response correlating with protection when pre and post exposure antibody levels were analysed. The predominant serotype of B. pertussis isolates has changed over time in most countries but it is not understood whether this is vaccine-driven or whether serotype is linked to the prevailing predominant genotype. Recent studies have shown that both Fim2 and Fim3 are expressed during infection and that Fim2 is more immunogenic than Fim3 in the acellular vaccine.
Insights
Bordetella pertussis fimbriae, Fim2 and Fim3, are key antigens in pertussis vaccines. Their expression is regulated, and Fim2 shows higher immunogenicity than Fim3 in acellular vaccines.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Bordetella pertussis expresses two distinct fimbriae, Fim2 and Fim3, crucial for whole-cell pertussis vaccines.
- Fimbrial expression is regulated by the BvgA/S system and poly(C) tract length.
- Anti-fimbriae antibodies correlate with protection in clinical trials of pertussis vaccines.
Purpose of the Study:
- To investigate the role and immunogenicity of Fim2 and Fim3 fimbriae in Bordetella pertussis.
- To understand the regulation of fimbrial expression and its impact on vaccine efficacy.
- To analyze the changing serotypes of B. pertussis isolates and their potential link to vaccination or genotype.
Main Methods:
- Analysis of fimbrial gene expression regulation by the BvgA/S system.
- Assessment of poly(C) tract length influence on Fim2 and Fim3 expression.
- Evaluation of anti-fimbriae antibody responses in relation to vaccine efficacy and protection.
Main Results:
- Both Fim2 and Fim3 fimbriae are expressed during B. pertussis infection.
- Fim2 is demonstrated to be more immunogenic than Fim3 in the context of acellular pertussis vaccines.
- The predominant serotype of B. pertussis isolates has shifted over time, with unclear links to vaccination or genotype.
Conclusions:
- Fim2 and Fim3 are significant antigens for pertussis vaccines, with Fim2 being more immunogenic.
- Understanding fimbrial expression and serotype dynamics is crucial for developing effective pertussis vaccines.
- Further research is needed to determine if serotype changes are vaccine-driven or linked to genetic factors.
Related Concept Videos
Fimbriae, Pili, and Axial Filaments
Vaccinations
Regulation of Bacterial Virulence
Diphtheria
Vaccines
Microorganisms in Medicine and Therapeutics

